Related Experiment Videos
Tumor markers kinetic in malignant lung neoplasms
R Cristofori1, G Aimo, G Mengozzi
1Department of Thoracic Surgery, S. Giovanni Battista Hospital, Turin, Italy.
The Journal of Cardiovascular Surgery
|June 1, 1999
Summary
Postoperative half-life of tumor markers like CEA and TPA can predict lung cancer prognosis. Longer CEA half-life in patients indicates a higher risk of relapse and metastasis after bronchogenic carcinoma surgery.
Area of Science:
- Oncology
- Biochemistry
- Medical Diagnostics
Background:
- Limited research exists on the correlation between postoperative tumor marker half-life and lung cancer prognosis.
- This study aimed to determine the half-life of CEA, TPA, NSE, and CYFRA 21-1 post-surgery for bronchogenic carcinoma.
- The objective was to correlate these half-lives with patient prognosis and survival rates.
Purpose of the Study:
- To establish the postoperative half-life of key tumor markers (CEA, TPA, NSE, CYFRA 21-1) in lung cancer patients.
- To investigate the relationship between these marker half-lives and patient outcomes, including relapse and survival.
- To evaluate the potential of these markers as prognostic tools in the postoperative period.
Main Methods:
- A cohort of 35 bronchogenic carcinoma patients (29 males, 6 females) were studied between March 1997 and March 1998.
- Tumor markers CEA and NSE were measured using immunoenzymatic methods, while TPA and CYFRA 21-1 were assayed via immunoradiometric techniques.
- Half-life calculations and dismissal curves for each marker were performed during the postoperative follow-up period.
Main Results:
- Preoperative TPA and CYFRA 21-1 levels showed statistically significant differences between squamous cell lung cancer (SqCLC) and adenocarcinoma.
- Preoperative marker levels were elevated in patients who later experienced relapse, though not always statistically significant.
- CEA half-life was 1.4 days, significantly longer (4.5 days) in patients with a history of relapse or metastasis; no significant difference was found for CYFRA 21-1.
Conclusions:
- Serial determination of CEA and TPA during postoperative follow-up can serve as a valuable prognostic indicator for bronchogenic carcinoma.
- Further extended follow-up studies are recommended to establish individual predictive thresholds for distinguishing between poor and good prognosis.
- The findings suggest that monitoring specific tumor marker kinetics post-surgery offers insights into lung cancer patient outcomes.